Veliparib | Veliparib : Inhibitor of PARP1 and PARP2
RATINGS:
Cellular Use: (3 reviews)

In Model Organisms: (2 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
PARP1
  • Ki:5.2 nM
  • IC 50:3.3 nM
  • IC 50:5.9 nM
PARP2
  • Ki:2.9 nM
  • IC 50:17.5 nM
  • IC50:PARP 5.9 nM
Inhibitor
10-100 nM

Selectivity

In Vitro Selectivity Assessment

Potency: Ki - SIRT2 >5,000 nM

Potency Assay Off-Target:
In ADP ribosylation assays for PARP family members, veliparib was >100-fold selective for PARP1 and ...
Selectivity Assessment Description:
In ADP ribosylation assays for PARP family members, veliparib was >100-fold selective for PARP1 and ...

Potency
Cellular
In Vitro

PARP1

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.6b00990

PARP2

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.6b00990

In Vivo Validations

mouse, rat
Dose: 10 mg/kg (mice), 5 mg/kg (rat)
Route of delivery: Intravenous, Oral
Plasma half life: 1.6 h (mouse IV), 1.2 h (rat IV), 1.3 h (mouse oral), 1.6 h (rat oral)
Systemic clearance: 4.1 L/h/kg (mouse IV), 2.0 L/h/kg (rat IV)
Organ of interest (O): xenograft tumor, brain, plasma
Target engagement assay: Indirect: in B16F10 tumors, velaparib inhibited PAR as detected in western blot.

DOI Reference: 10.1158/1078-0432.CCR-06-3039

Orthogonal Probes def

OLAPARIB
TALAZOPARIB
NIRAPARIB

Chemical Information

Molecular Formula C13H16N4O
SMILEs C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1
InChI InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1
Molecular weight 244.13 Da
AlogP 1.2604
HBond acceptors 5
HBond donors 4
Atoms 34

References

Cross References

GDSC

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 1 Aug 2016 )
Cellular Use Rating
In Model Organisms
Veliparib is a PARP 1/2 inhibitor. This agent is an excellent tool to study PARP inhibition in both the cellular and in vivo setting. However, an important study about the mechanism of these probes...
(on 9 Sept 2016 )
Cellular Use Rating
In Model Organisms
Velaparib is not overly potent in vivo as a a single agent but potentiates both chemo- and radiotherapy. Like other PARP inhibitors, veliparib is a potent inhibitor of PARP1 and 2 but not the other...
(on 17 Jan 2017 )
Cellular Use Rating
Veliparib is a potent dual PARP1/2 inhibitor. It is highly recommended for studying the function of these targets in vitro. Veliparib has also shown utility in in vivo studies and even some degree of...
Veliparib is a PARP1/2 inhibitor with selectivity sufficient for cellular work to interrogate PARP1/2. While target engagement has been shown in vivo at modest doses, the lack of receptor profiling...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria